Fluoxetine (Prozac) Dose Titration
For adults with major depressive disorder, start fluoxetine at 20 mg once daily in the morning, and if dose escalation is needed after several weeks of insufficient response, increase in 20 mg increments to a maximum of 80 mg/day. 1
Initial Dosing
Adults:
- Starting dose: 20 mg/day, administered in the morning 1
- This dose is sufficient to obtain satisfactory response in most cases of major depressive disorder
- No titration is required—patients can start at the therapeutic dose
Older Adults:
- Use lower or less frequent dosing 1
- Consider starting at 10 mg every other morning, particularly in those with multiple comorbidities or concurrent medications 2
- Fluoxetine has a very long half-life, and side effects may not manifest for several weeks 2
Dose Adjustments and Titration
When to increase:
- Consider dose increase after several weeks if insufficient clinical improvement is observed 1
- Full therapeutic effect may be delayed until 4 weeks of treatment or longer 1
- For anxiety disorders in children/adolescents, guidelines suggest slower titration at approximately 3-4 week intervals due to fluoxetine's longer half-life 3
How to increase:
- Increase by 20 mg increments 1
- Doses above 20 mg/day may be given once daily (morning) or twice daily (morning and noon) 1
- Maximum dose: 80 mg/day 1
Special Considerations
Hepatic Impairment:
- Use lower or less frequent dosing 1
Renal Impairment:
- Dosage adjustments not routinely necessary 1
Pediatric Patients (Depression):
- Start at 10 or 20 mg/day
- After 1 week at 10 mg/day, increase to 20 mg/day
- Lower weight children may require only 10 mg/day as target dose 1
Common Pitfalls to Avoid
Starting too high: Some patients, particularly those with panic disorder, cannot tolerate 20 mg/day initially. Research shows 28% of patients were unable to reach 20 mg/day, with half discontinuing entirely 4. For these patients, starting at 5-10 mg/day with gradual titration over 1 week may improve tolerability.
Increasing too quickly: Due to fluoxetine's long half-life (4 days after chronic dosing, with active metabolite norfluoxetine having 7-day half-life), steady-state is not reached for several weeks 5. Increasing doses before 3-4 weeks may lead to unintentional overdosing once steady-state is achieved.
Premature discontinuation: The logarithmic response model shows statistically significant improvement within 2 weeks, but clinically significant improvement typically occurs by week 6, with maximal improvement by week 12 or later 3. Patients and clinicians should be counseled about this delayed response.
CYP2D6 poor metabolizers: Patients who are CYP2D6 poor metabolizers have 3.9 to 11.5-fold higher drug exposure 6. The FDA has issued safety warnings about QT prolongation risk in CYP2D6 poor metabolizers 6. Consider lower starting doses or genetic testing in patients with concerning cardiac history.
Maintenance Dosing
Once remission is achieved, continue the effective dose for at least 4 months for first episode depression 7. Systematic evaluation shows efficacy is maintained at 20 mg/day for up to 38 weeks following acute treatment 1.